Loading…
Ascentage Pharma Group Internat is projected to rise to $25.85 by 2027, a +29% move from its current price of $19.97. AAPG is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $19.48 | $19.98 | $20.49 | +0.03% |
| Jul 14 | $19.28 | $19.98 | $20.71 | +0.05% |
| Jul 15 | $19.13 | $19.99 | $20.88 | +0.08% |
| Jul 16 | $19.01 | $19.99 | $21.02 | +0.10% |
| Jul 17 | $18.90 | $20.00 | $21.16 | +0.13% |
| Jul 18 | $18.80 | $20.00 | $21.27 | +0.15% |
| Jul 19 | $18.71 | $20.01 | $21.39 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $18.71 | $20.01 | $21.39 | +0.18% |
| Week 2 | $18.24 | $20.04 | $22.02 | +0.35% |
| Week 3 | $17.88 | $20.08 | $22.54 | +0.53% |
| Week 4 | $17.60 | $20.11 | $22.98 | +0.71% |
| Week 5 | $17.35 | $20.15 | $23.39 | +0.89% |
| Week 6 | $17.14 | $20.18 | $23.77 | +1.07% |
| Week 7 | $16.95 | $20.22 | $24.12 | +1.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ascentage Pharma Group International is a clinical-stage biotechnology company focused on developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company’s primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation.
The company also develops APG-2575, APG-115, APG-1252, APG-1387, and APG-5918, and is involved in medical research and development; clinical development; clinical trials operations; venture capital investment; rental of buildings; and promotion of science and technology.
Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China, and it has collaboration relationships with biotechnology and pharmaceutical companies and research institutions.
AAPG is a healthcare stock currently trading at $19.97 per share, with a market capitalization of $1.86B and a market rank of 2090.
The forecast path shows evolving upside, with 2026 forecast values of min $16.77, avg $19.97, max $27.18 and an ROI of 0% (neutral sentiment).
From 2027 onward, the outlook shifts to bullish, with rising averages through 2035 and beyond, culminating in an average price of $146.44 by 2050 and an ROI of 633.3%.
A major floor 21.5% below — a decisive break under it would weaken the trend.
The nearest floor, 16.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.2% away) — a breakout level to watch.
A major ceiling 37.3% above — clearing it would confirm fresh momentum.
Key AAPG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AAPG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.16 | Buy | $19.12 | Buy |
| MA 10 | $18.43 | Buy | $18.64 | Buy |
| MA 20 | $17.79 | Buy | $18.36 | Buy |
| MA 50 | $19.18 | Buy | $19.41 | Buy |
| MA 100 | $21.76 | Sell | $21.58 | Sell |
| MA 200 | $26.33 | Sell | $24.30 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.24 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 188.54 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.40 | Buy |
| ROC (12) | 17.40 | Buy |
| Bollinger %B (20,2) | 1.10 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.29 | Sell |
| Awesome (5,34) | 0.90 | Buy |
| Ultimate (7,14,28) | 75.72 | Sell |
| Momentum (10) | 2.92 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 19.44 | Buy |
| ADX (14) | 21.39 | Buy |
| ATR (14) | 0.43 | Info |
The 30-day technical picture is bullish. RSI14 is 60, indicating momentum near the upper end of the neutral range.
The 50-day simple moving average is $19.18 and the 200-day simple moving average is $26.33, suggesting near-term upside pressure and longer-term resistance.
Support is identified at $16.77 and resistance at $20.01, with the 30-day trading range between $16.91 and $23.58.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.77 | $19.97 | $27.18 | 0% | Neutral | |
| $20.73 | $25.85 | $34.02 | +29% | Bullish | |
| $23.70 | $30.33 | $41.32 | +52% | Bullish | |
| $24.70 | $32.28 | $45.18 | +62% | Bullish | |
| $26.67 | $35.52 | $50.86 | +78% | Bullish | |
| $27.06 | $36.65 | $53.54 | +84% | Bullish | |
| $26.30 | $36.18 | $53.80 | +81% | Bullish | |
| $30.65 | $42.80 | $64.69 | +114% | Bullish | |
| $35.34 | $50.04 | $76.77 | +151% | Bullish | |
| $37.99 | $54.52 | $84.81 | +173% | Bullish | |
| $45.08 | $68.72 | $113.33 | +244% | Bullish | |
| $86.66 | $146.44 | $263.01 | +633% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $16.77 | $19.97 | $23.37 | +0.00% |
| August 2026 | $16.59 | $19.54 | $23.61 | -2.16% |
| September 2026 | $17.23 | $20.43 | $24.95 | +4.59% |
| October 2026 | $17.67 | $21.06 | $25.94 | +3.08% |
| November 2026 | $17.61 | $21.09 | $26.16 | +0.12% |
| December 2026 | $18.10 | $21.77 | $27.18 | +3.22% |
Click any year to see its month-by-month AAPG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, AAPG could reach as high as $27.18, with a base case around $19.97 and support toward $16.77 — roughly 0% from $19.97. Price action looks broadly range-bound.
Expect AAPG to range from $20.73 to $34.02 through 2027. The $25.85 average target implies a +29% move from current prices. That is up +29% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The AAPG price prediction for 2028 points to an average of $30.33 (low $23.70, high $41.32) — a potential gain of +52% on today's $19.97. Momentum favours further upside here.
In 2029, AAPG is projected to trade between $24.70 and $45.18, averaging $32.28 — a potential gain of +62% from today's $19.97. That is up +6% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Ascentage Pharma Group Internat's 2030 outlook centres on $35.52, within a $26.67 to $50.86 range. That is up +10% on the projected 2029 average. That marks a +78% change versus current levels. Momentum favours further upside here.
By 2031, AAPG could reach as high as $53.54, with a base case around $36.65 and support toward $27.06 — roughly +84% from $19.97. Buyers look set to stay in control over this stretch.
Expect AAPG to range from $26.30 to $53.80 through 2032. The $36.18 average target implies a +81% move from current prices. That is -1% versus the projected 2031 average. Momentum favours further upside here.
The AAPG price prediction for 2033 points to an average of $42.80 (low $30.65, high $64.69) — a potential gain of +114% on today's $19.97. Buyers look set to stay in control over this stretch.
In 2034, AAPG is projected to trade between $35.34 and $76.77, averaging $50.04 — a potential gain of +151% from today's $19.97. That is up +17% on the projected 2033 average. Momentum favours further upside here.
Ascentage Pharma Group Internat's 2035 outlook centres on $54.52, within a $37.99 to $84.81 range. That is up +9% on the projected 2034 average. That marks a +173% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, AAPG could reach as high as $113.33, with a base case around $68.72 and support toward $45.08 — roughly +244% from $19.97. Momentum favours further upside here.
Expect AAPG to range from $86.66 to $263.01 through 2050. The $146.44 average target implies a +633% move from current prices. That is up +113% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in AAPG today (≈ 50.075113 AAPG) could be worth
$7,333.23
+$6,333.23 (+633%) by 2050 · US Dollar
Based on the average projected AAPG price of $146.44 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AAPGwould be worth at today's price.
$1,000 invested in AAPG on Jul 10, 2025 (≈ 24.5459 AAPG) would be worth
$490.18
-$509.82 (-51.0%) today · 0.49× · US Dollar
Based on a AAPG entry price of $40.74 vs. today's $19.97.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.5 | $1,079.46 | +7.9% |
| 1 month ago | $17.07 | $1,169.89 | +17.0% |
| 3 months ago | $25.33 | $788.39 | -21.2% |
| 6 months ago | $28.38 | $703.66 | -29.6% |
| 1 year ago | $40.74 | $490.18 | -51.0% |
| All time (1.5y) ago | $17.38 | $1,149.02 | +14.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AAPG forecast.
Our base-case forecast reaches $40.00 around 2033.
Implied market cap at $40.00: $3.73B
The multi-year forecast shows meaningful upside, with the average price rising from $19.97 in 2026 to $146.44 in 2050 and a long-run bullish sentiment across most years.
Key year-by-year anchors include 2027 avg $25.85 (ROI 29.4%, sentiment BULLISH), 2028 avg $30.33 (ROI 51.9%), 2029 avg $32.28 (ROI 61.6%), 2030 avg $35.52 (ROI 77.8%), 2031 avg $36.65 (ROI 83.5%), 2032 avg $36.18 (ROI 81.2%), 2033 avg $42.80 (ROI 114.3%), 2034 avg $50.04 (ROI 150.6%), 2035 avg $54.52 (ROI 173%), 2040 avg $68.72 (ROI 244.1%), and 2050 avg $146.44 (ROI 633.3%), with bullish sentiment through 2050.
These figures illustrate a sustained upside trajectory, but they are estimates, not guarantees, and should be considered in the context of inherent market uncertainty and risk.
Tap a question to reveal the answer.
In 2030, the forecast shows min $26.67, avg $35.52, max $50.86 with ROI 77.8% and bullish sentiment.
The forecast indicates bullish sentiment from 2027 onward, with rising average prices and ROI reaching 83.5% in 2031 and 633.3% by 2050, though these are estimates and not guarantees.
Yes, the forecast max reaches $50.86 in 2030, with earlier years showing rising highs (e.g., 2027 max $34.02).
Current price is $19.97 and market capitalization is $1.86B.
The 30-day picture shows bullish sentiment, RSI14 at 60, SMA50 at $19.18, SMA200 at $26.33, with support at $16.77 and resistance at $20.01; the 30-day range is $16.91–$23.58.
Ascentage Pharma Group Internat Community Discussion
0Share your Ascentage Pharma Group Internat price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.